McCarthy Rebecca L, Oldham Jaimie, Barbosa Elsa, Sinclair Catriona, Cunningham Malvina, O'Toole Edel A
Faculty of Medicine and Dentistry Centre for Cell Biology and Cutaneous Research Blizard Institute Queen Mary University of London London UK.
Department of Dermatology Royal London Hospital Barts Health NHS Trust London UK.
Skin Health Dis. 2024 Apr 11;4(4):e389. doi: 10.1002/ski2.389. eCollection 2024 Aug.
Pityriasis rubra pilaris (PRP) is a rare skin disease which manifests as a psoriasiform dermatosis and palmoplantar keratoderma and has significant clinical-histopathological overlap with psoriasis. Recently, several case reports have demonstrated successful treatment of PRP with anti-IL7A and anti-IL12/anti-IL23 monoclonal antibodies. We report a case of atypical juvenile PRP definitively diagnosed during adulthood with presence of CARD14 mutation. This case demonstrates a dramatic improvement with ustekinumab and highlights the role of genetic testing in chronic disease of diagnostic uncertainty.
红皮病型毛发红糠疹(PRP)是一种罕见的皮肤病,表现为银屑病样皮疹和掌跖角化病,在临床组织病理学上与银屑病有显著重叠。最近,几例病例报告显示,抗IL7A和抗IL12/抗IL23单克隆抗体成功治疗了PRP。我们报告一例成年期确诊的非典型青少年PRP病例,该病例存在CARD14突变。该病例显示乌司奴单抗治疗效果显著,并突出了基因检测在诊断不明确的慢性病中的作用。